Sangui - Perle im Biotechsektor bald 1ooo % ? (Seite 6812)
eröffnet am 12.05.04 20:12:51 von
neuester Beitrag 26.03.24 17:06:19 von
neuester Beitrag 26.03.24 17:06:19 von
Beiträge: 79.773
ID: 859.129
ID: 859.129
Aufrufe heute: 6
Gesamt: 5.268.982
Gesamt: 5.268.982
Aktive User: 0
ISIN: US80105B1017 · WKN: 906757 · Symbol: SBH
0,0010
EUR
0,00 %
0,0000 EUR
Letzter Kurs 08:16:04 Hannover
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,9000 | +59,66 | |
7,5700 | +48,14 | |
0,5922 | +44,44 | |
11,940 | +43,86 | |
4,7450 | +35,57 |
Wertpapier | Kurs | Perf. % |
---|---|---|
2,6700 | -12,17 | |
8,0100 | -12,85 | |
9,9200 | -15,07 | |
2,1450 | -20,85 | |
1,6052 | -30,21 |
Beitrag zu dieser Diskussion schreiben
[posting]18.066.893 von RTLOLDY am 28.09.05 20:04:01[/posting]sich = gestrichen
dich = eingefügt
dich = eingefügt
[posting]18.066.847 von lenny007 am 28.09.05 20:02:17[/posting]Deine Unwissenheit schütz sich vor Tadel !
eure Geduld ist bewundernswert, fürchte nur das euer warten
nicht belohnt wird.
nicht belohnt wird.
Jörg du hast
@traumstrand
da gebe ich dir recht! sind ziemlich günstig!
ich hoffe auch, daß da bald was kommt.
liedermann
da gebe ich dir recht! sind ziemlich günstig!
ich hoffe auch, daß da bald was kommt.
liedermann
@ liederman:
Doch, sehr schön - hab aufgestockt, m.E. preisgünstig. Ich erwarte von den nächsten Wochen einiges Positives (nur meine ganz persönliche Auffassung).
Gruß, ts.
Doch, sehr schön - hab aufgestockt, m.E. preisgünstig. Ich erwarte von den nächsten Wochen einiges Positives (nur meine ganz persönliche Auffassung).
Gruß, ts.
sieht ja nicht gerade gut aus!!!
SANGUI BIOTECH INTL INC. Reg..
Börse: Hamburg
Datum: 28.09.05
Zeit Kurs Volumen
14:27:44 0,121 10000
13:23:01 0,122 20000
13:00:55 0,122 10000
11:21:17 0,125 21928
09:19:04 G 0,125 0
liedermann
SANGUI BIOTECH INTL INC. Reg..
Börse: Hamburg
Datum: 28.09.05
Zeit Kurs Volumen
14:27:44 0,121 10000
13:23:01 0,122 20000
13:00:55 0,122 10000
11:21:17 0,125 21928
09:19:04 G 0,125 0
liedermann
Jedem das was ihm gebührt....
dann hat das Hungern ja ein ENDE
dann hat das Hungern ja ein ENDE
SEC EDGAR Submission 0001093094-05-000024
www.sec.gov/Archives/edgar/data/1104280/000109309405000024/0001093094-05-00...
Published on: 2/25/2005 Last Visited: 3/1/2005
Prof. Wolfgang Barnikol, M.D., Ph.D: Arndtstr. 8 58453 Witten
...
The Company has an agreement with Professor Barnikol, the Company`s President and CEO, pursuant to which he is entitled to 3% royalties of gross revenues earned with any product based on his inventions.
...
Prof. Wolfgang Barnikol, M.D.,
...
PROFESSOR WOLFGANG K. R. BARNIKOL, M.D., Ph.D., Chairman, President, Chief Executive Officer, Chief Financial Officer, and Executive Director of SGBI, has studied chemistry, physics and medicine at the Universities of Munster, Aachen and Mainz, Germany. In 1961, he received a Diploma in chemistry from University of Mainz, Mainz, Germany. In 1964, he obtained the doctorate in physical chemistry (Dr. rer. nat.) and in 1973 the doctorate in medicine (Dr. med.) both from the University of Mainz, Mainz, Germany. In that same year, he also was appointed professor in medical physiology at University of Mainz, Mainz Germany. In 1996, Dr. Barnikol was awarded a specialist in medical physiology by the medical association of Rheinland-Pfalz Germany. His research interest in physical chemistry focused on the polymerization of styrene and the determination of molecular weights of polymers with the electron microscope. Dr. Barnikol`s research areas in medicine are: (i) respiration; and (ii) blood and circulation. In the field of respiration, he works on the functional analysis of the bronchial system and gas exchange. Moreover, he is engaged in the development of respiratory and skin oxygen sensors. In the field of blood and circulation, he works on the development of artificial oxygen carriers for medical use, which are based on polymerised soluble hemoglobins. As a third sphere of work, Dr. Barnikol is engaged in the development of an implantable glucose sensor. Dr. Barnikol has published more than 100 scientific articles, a textbook in physiology and a review on the situation of German universities.
www.sec.gov/Archives/edgar/data/1104280/000109309405000024/0001093094-05-00...
Published on: 2/25/2005 Last Visited: 3/1/2005
Prof. Wolfgang Barnikol, M.D., Ph.D: Arndtstr. 8 58453 Witten
...
The Company has an agreement with Professor Barnikol, the Company`s President and CEO, pursuant to which he is entitled to 3% royalties of gross revenues earned with any product based on his inventions.
...
Prof. Wolfgang Barnikol, M.D.,
...
PROFESSOR WOLFGANG K. R. BARNIKOL, M.D., Ph.D., Chairman, President, Chief Executive Officer, Chief Financial Officer, and Executive Director of SGBI, has studied chemistry, physics and medicine at the Universities of Munster, Aachen and Mainz, Germany. In 1961, he received a Diploma in chemistry from University of Mainz, Mainz, Germany. In 1964, he obtained the doctorate in physical chemistry (Dr. rer. nat.) and in 1973 the doctorate in medicine (Dr. med.) both from the University of Mainz, Mainz, Germany. In that same year, he also was appointed professor in medical physiology at University of Mainz, Mainz Germany. In 1996, Dr. Barnikol was awarded a specialist in medical physiology by the medical association of Rheinland-Pfalz Germany. His research interest in physical chemistry focused on the polymerization of styrene and the determination of molecular weights of polymers with the electron microscope. Dr. Barnikol`s research areas in medicine are: (i) respiration; and (ii) blood and circulation. In the field of respiration, he works on the functional analysis of the bronchial system and gas exchange. Moreover, he is engaged in the development of respiratory and skin oxygen sensors. In the field of blood and circulation, he works on the development of artificial oxygen carriers for medical use, which are based on polymerised soluble hemoglobins. As a third sphere of work, Dr. Barnikol is engaged in the development of an implantable glucose sensor. Dr. Barnikol has published more than 100 scientific articles, a textbook in physiology and a review on the situation of German universities.
15.05.23 · EQS Group AG · Sangui Biotech International |
15.05.23 · EQS Group AG · Sangui Biotech International |